Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | SAKAR Sakar Healthcare Limited Pharma · Small | KRSNAA Krsnaa Diagnostics Limited Pharma · Small | MOREPENLAB Morepen Laboratories Limited Pharma · Small | SURAKSHA Suraksha Diagnostic Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 37 | 46 | 27 | 51 |
| Verdict | WATCHLIST | FAIR VALUE | OVERVALUED | FAIR VALUE |
| Style | WATCHLIST | Financial Turnaround | OVERVALUED | Financial Turnaround |
| Piotroski | 8/9 | 8/9 | 7/9 | 8/9 |
| Valuation | 0/30 | 19/30 | 5/30 | 2/30 |
| Growth | 17/25 | 13/25 | 4/25 | 21/25 |
| Quality | 1/20 | 1/20 | 0/20 | 8/20 |
| Balance Sheet | 9/15 | 6/15 | 9/15 | 7/15 |
| Cash Flow | 5/10 | 1/10 | 4/10 | 8/10 |
| Price | ₹813.6 | ₹544.35 | ₹48.65 | ₹269.65 |
| P/E | 56.00 | 17.10 | 31.60 | 44.60 |
| P/B | 5.26 | 1.77 | 1.88 | 5.87 |
| ROE | 9.99% | 10.90% | 6.20% | 14.10% |
| ROCE | 12.70% | 12.70% | 8.05% | 17.00% |
| Debt / Equity | 0.17 | 0.54 | 0.17 | 0.53 |
| FCF Yield | 1.23% | — | — | 2.09% |
| Dividend Y | — | 0.51% | 0.47% | — |
| Altman Z | 8.12 | 2.98 | 5.05 | 6.54 |
| Promoter % | 52.86% | 27.11% | 35.66% | 49.10% |
| Mkt Cap (₹Cr) | 1708.00 | 1737.00 | 2349.00 | 1436.00 |
| Graham # | ₹212.14 | ₹460.96 | ₹29.79 | ₹80.84 |
| Fair PE | 42.0 | 30.3 | 5.4 | 42.0 |
| MoS % | -41.4% | +42.5% | -420.7% | -3.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startSAKAR260
KRSNAA58
MOREPENLAB58
SURAKSHA65